North American Neuromodulation Society

Mission Statement

The North American Neuromodulation Society (NANS) is dedicated to being the premier organization representing neuromodulation. NANS promotes multidisciplinary collaboration among clinicians, scientists, engineers, and others to advance neuromodulation through education, research, innovation and advocacy. Through these efforts NANS seeks to promote and advance the highest quality patient care.

Definition

Neuromodulation is the application of targeted electrical, chemical and biological technologies to the nervous system in order to improve function and quality of life.

NANS Vision Statement

  • NANS will work to expand the scope of neuromodulation as new technologies and treatments become available.
  • NANS will work to expand the breadth of its membership to involve all disciplines that develop and deliver neuromodulation therapies.
  • NANS will strive to ensure that its’ clinician members are recognized as the pre-eminent providers of quality care to patients who may benefit from neuromodulation therapies.
  • NANS will be its members’ principal resource for continuing education, professional interaction and clinical strategies to promote optimal utilization of neuromodulation therapies.
  • NANS will develop, disseminate, and maintain guidelines that promote patient safety, cost effectiveness, and appropriate patient selection for neuromodulation therapies.
  • NANS will promote awareness and advocate for neuromodulation therapies through its communications and interactions with the public, media, government, medical communities, and third party payers.
  • NANS will work with other societies, government, third party payers, and patients to maintain access to neuromodulation therapies.
  • NANS will promote and support clinical and basic science research to improve the understanding of the mechanisms, expand the scope of, and enhance the evidence base support for the use of neuromodulation therapies.

WIKISTIM

WIKISTIM is a searchable database being populated with data published in the field of neuromodulation. The goals of WIKISTIM are to improve patient care and the quality of research reports, foster communication, reveal research needs, and support the practice of evidence–based medicine.

Upcoming Events

  • June 26-29 2017

    17th Quadrennial Meeting of the WSSFN
    Hotel Intercontinental
    Berlin, Germany
    www.wssfn-congress.org

  • July 17-18, 2017

    14th World Congress on Neurology and
    Neurological Disorders
    Chicago, IL
    neuro.conferenceseries.com

  • August 28–30, 2017

    The 22nd Annual Gabor Racz Advanced
    Interventional Budapest Pain
    Conference and Workshop
    Budapest, Hungary
    www.congressline.hu/pain2017/

Contains 0 items
Subtotal: $0.00